Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management

Pediatrics

Volumn 129, Issue 6, 2012, Pages

  Rosato, Nancy Scotto ^a   Correll, Christoph U ^b   Pappadopulos, Elizabeth ^c   Chait, Alanna ^d   Crystal, Stephen ^e   Jensen, Peter S ^d,f  

^a STATE OF NEW JERSEY   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c PFIZER INC   (United States)

^d REsource for Advancing Children's Health   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Aggression; Behavior disorders problems; Guidelines; Psychosocial intervention; Psychotropic drugs

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; ADULT; AGGRESSION; ALERTNESS; ANGER; AUTISM; BEHAVIOR THERAPY; CARDIOVASCULAR RISK; CHILD; CHILD PARENT RELATION; CONDUCT DISORDER; CONSENSUS; CONTROLLED STUDY; DRUG TOLERABILITY; HUMAN; HYPERPROLACTINEMIA; IMPULSIVENESS; INSOMNIA; MALADJUSTMENT; MENTAL HEALTH CARE PERSONNEL; OPPOSITIONAL DEFIANT DISORDER; PATIENT ADVOCACY; PHYSICIAN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RATING SCALE; REVIEW; SCHOOL CHILD; SEDATION; SIDE EFFECT; SKILL; SOCIAL PSYCHOLOGY; SOMNOLENCE; TREATMENT RESPONSE; VIOLENCE; WEIGHT GAIN;

ADOLESCENT; AGGRESSION; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 84861876338     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1361     Document Type: Review

References (61)

1. Kronenberger WG, Giauque AL, Dunn DW. Development and validation of the outburst monitoring scale for children and adolescents. J Child Adolesc Psychopharmacol. 2007;17(4):511-526 (Pubitemid 47417778)
2. Loeber R, Farrington DP, eds. Child Delinquents: Development, Intervention, and Service Needs. Thousand Oaks, CA: SAGE Publications; 2001
3. Webster-Stratton C, Hammond M. Conduct problems and level of social competence in Head Start children: prevalence, pervasiveness, and associated risk factors. Clin Child Fam Psychol Rev. 1998;1(2):101-124 (Pubitemid 128692962)
4. Campbell M, Malone RP. Mental retardation and psychiatric disorders. Hosp Community Psychiatry. 1991;42(4):374-379
5. Schur SB, Sikich L, Findling RL, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry. 2003;42(2):132-144 (Pubitemid 39610593)
6. Martin A, Leslie D. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997- 2000. Am J Psychiatry. 2003;160(4):757-764 (Pubitemid 41079610)
7. Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA. New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med. 2004; 158(8):753-759 (Pubitemid 39025073)
8. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry. 2006;63 (6):679-685 (Pubitemid 43848299)
9. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T. Increasing use of atypical antipsychotic drugs: challenges for policymakers, clinicians and patients. Health Aff. 2012, In press
10. Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006;6(2):79-83 (Pubitemid 43960577)
11. Kazdin AE, Marciano PL, Whitley MK. The therapeutic alliance in cognitive-behavioral treatment of children referred for oppositional, aggressive, and antisocial behavior. J Consult Clin Psychol. 2005;73(4):726-730 (Pubitemid 41368401)
12. Pappadopulos E, Scotto Rosato N, Correll CU, Findling R, Lucas J, Crystal S, Jensen PS. Experts' recommendations for treating maladaptive aggression in youth. J Child Adol Psychopharm. 2011;21(6):505-515
13. Knapp P, Chait A, Pappadopulos E, Crystal S, Jensen PS. Treatment of maladaptive aggression in youth. CERT Guidelines I. Engagement, assessment, & management. Pediatrics. 2012; 129(6):XXX-XXX
14. Pappadopulos E, Woolston S, Chait A, Perkins M, Connor DF, Jensen PS. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry. 2006;15(1):27-39
15. Citrome L. Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand. 2008;117(6):412-419 (Pubitemid 351678479)
16. Cohen J. A power primer. Psychol Bull. 1992;112(1):155-159
17. Eyberg SM, Nelson MM, Boggs SR. Evidencebased psychosocial treatments for children and adolescents with disruptive behavior. J Clin Child Adolesc Psychol. 2008;37(1): 215-237
18. Fossum S, Handegård BH, Martinussen M, Mørch WT. Psychosocial interventions for disruptive and aggressive behaviour in children and adolescents: a meta-analysis. Eur Child Adolesc Psychiatry. 2008;17(7):438-451
19. Nixon RD. Treatment of behavior problems in preschoolers: a review of parent training programs. Clin Psychol Rev. 2002;22(4): 525-546 (Pubitemid 34462892)
20. Thomas R, Zimmer-Gembeck MJ. Behavioral outcomes of Parent-Child Interaction Therapy and Triple P-Positive Parenting Program: a review and meta-analysis. J Abnorm Child Psychol. 2007;35(3):475-495 (Pubitemid 46980445)
21. Feinfield KA, Baker BL. Empirical support for a treatment program for families of young children with externalizing problems. J Clin Child Adolesc Psychol. 2004;33(1):182-195 (Pubitemid 38341559)
22. Landy S, Menna R. An evaluation of a group intervention for parents with aggressive young children: improvements in child functioning, maternal confidence, parenting knowledge and attitudes. Early Child Dev Care. 2006;176(6):605-620
23. Barkley RA, Shelton TL, Crosswait C, et al. Multi-method psycho-educational intervention for preschool children with disruptive behavior: preliminary results at posttreatment. J Child Psychol Psychiatry. 2000; 41(3):319-332 (Pubitemid 30153649)
24. Larsson B, Fossum S, Clifford G, Drugli MB, Handegård BH, Mørch WT. Treatment of oppositional defiant and conduct problems in young Norwegian children: results of a randomized controlled trial. Eur Child Adolesc Psychiatry. 2009;18(1):42-52
25. Webster-Stratton C, Reid J, Hammond M. Social skills and problem-solving training for children with early-onset conduct problems: who benefits? J Child Psychol Psychiatry. 2001;42(7):943-952 (Pubitemid 33009376)
26. Reid MJ, Webster-Stratton C, Baydar N. Halting the development of conduct problems in Head Start children: the effects of parent training. J Clin Child Adolesc Psychol. 2004;33(2):279-291 (Pubitemid 38670840)
27. Bagner DM, Eyberg SM. Parent-child interaction therapy for disruptive behavior in children with mental retardation: a randomized controlled trial. J Clin Child Adolesc Psychol. 2007;36(3):418-429
28. Littell J, Popa M, Forsythe B. Multisystemic therapy for social, emotional, and behavioral problems in youth aged 10-17. Cochrane Database Syst Rev. 2005;(3):CD004797
29. Alexander JF, Parsons BV. Functional Family Therapy: Principles and Procedures. Carmel, CA: Brooks/Cole; 1982
30. Sexton TL, Alexander JF. Functional family therapy for externalizing disorders in adolescents. In: Lebow J, ed. Handbook of Clinical Family Therapy. Hoboken, NJ: Wiley; 2005: 164-194
31. Alexander JF, Parsons BV. Short-term behavioral intervention with delinquent families: impact on family process and recidivism. J Abnorm Psychol. 1973;81(3):219-225
32. Kazdin AE. Psychotherapy for children and adolescents. Annu Rev Psychol. 2003;54: 253-276 (Pubitemid 37417494)
33. Lochman JE, Wells KC. Contextual socialcognitive mediators and child outcome: a test of the theoretical model in the Coping Power program. Dev Psychopathol. 2002;14(4):945-967 (Pubitemid 351480069)
34. Lochman JE, Wells KC. Effectiveness study of Coping Power and classroom intervention with aggressive children: outcomes at a oneyear follow-up. Behav Ther. 2003;34(4):493-515 (Pubitemid 38821755)
35. Lochman JE, Wells KC. The coping power program for preadolescent aggressive boys and their parents: outcome effects at the 1-year follow-up. J Consult Clin Psychol. 2004;72(4):571-578 (Pubitemid 38988832)
36. Zonnevylle-Bender MJS, Matthys W, van de Wiel NMH, Lochman JE. Preventive effects of treatment of disruptive behavior disorder in middle childhood on substance use and delinquent behavior. J Am Acad Child Adolesc Psychiatry. 2007;46(1):33-39 (Pubitemid 46036977)
37. Dodge KA, Coie JD, Pettit GS, Price JM. Peer status and aggression in boys' groups: developmental and contextual analyses. Child Dev. 1990;61(5):1289-1309
38. Jensen PS, Youngstrom EA, Steiner H, et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry. 2007;46(3):309-322
39. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry. 2005;162(7):1361-1369
40. Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry. 2006;163(3):402-410 (Pubitemid 44469381)
41. Steiner H, Petersen ML, Saxena K, Ford S, Matthews Z. Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. J Clin Psychiatry. 2003;64(10):1183-1191
42. Blader JC. Symptom, family, and service predictors of children's psychiatric rehospitalization within one year of discharge. J Am Acad Child Adolesc Psychiatry. 2004; 43(4):440-451 (Pubitemid 38812384)
43. Kafantaris V. Treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(6):732-741
44. Pliszka SR, Crismon ML, Hughes CW, et al Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45 (6):642-657 (Pubitemid 43833097)
45. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1997;54(12): 1073-1080 (Pubitemid 27524371)
46. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086
47. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M; Child Psychiatric Workgroup on Bipolar Disorder. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):213-235 (Pubitemid 40299835)
48. Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein RE; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics. 2007;120(5). Available at: www.pediatrics. org/cgi/content/full/120/5/e1313
49. Lieberman JA, Stroup TS, McEvoy JP, et al Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209-1223 (Pubitemid 41345943)
50. Kahn RS, Fleischhacker WW, Boter H, et al; EUFEST study group. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371(9618):1085-1097 (Pubitemid 351418005)
51. Sikich L, Frazier JA, McClellan J, et al. Double-blind comparison of first- and second-generation antipsychotics in earlyonset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry. 2008; 165(11):1420-1431
52. Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(1):9-20
53. Correll CU, Kane JM. One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review. J Child Adolesc Psychopharmacol. 2007;17(5):647-656
54. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765-1773
55. Kumra S, Herion D, Jacobsen LK, Briguglia C, Grothe D. Case study: risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry. 1997;36(5): 701-705 (Pubitemid 27184079)
56. Aman MG, Novotny S, Samango-Sprouse C, et al. Outcome measures for clinical drug trials in autism. CNS Spectr. 2004;9(1):36-47 (Pubitemid 38419005)
57. Nickel MK, Muehlbacher M, Kaplan P, et al. Influence of family therapy on bullying behaviour, cortisol secretion, anger, and quality of life in bullying male adolescents: a randomized, prospective, controlled study. Can J Psychiatry. 2006;51(6):355-362 (Pubitemid 43854468)
58. Santisteban DA, Coatsworth JD, Perez-Vidal A, et al. Efficacy of brief strategic family therapy in modifying Hispanic adolescent behavior problems and substance use. J Fam Psychol. 2003;17(1):121-133 (Pubitemid 36385684)
59. Aman MG, McDougle CJ, Scahill L, et al; the Research Units on Pediatric Psychopharmacology Autism Network. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2009;48(12):1143-1154
60. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89(5):485-491 (Pubitemid 15104762)
61. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1986; 143(1):35-39 (Pubitemid 16185859)